Skip to main content
NCBI home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 1994 Apr;63(1):103–107.

Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.

E P McCoy 1, C Renfrew 1, J R Johnston 1, G Lavery 1
PMCID: PMC2449097  PMID: 8658983

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allsop P., Twigley A. J. The neuroleptic malignant syndrome. Case report with a review of the literature. Anaesthesia. 1987 Jan;42(1):49–53. doi: 10.1111/j.1365-2044.1987.tb02944.x. [DOI] [PubMed] [Google Scholar]
  2. Brown C., Osterloh J. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') JAMA. 1987 Aug 14;258(6):780–781. [PubMed] [Google Scholar]
  3. Chadwick I. S., Curry P. D., Linsley A., Freemont A. J., Doran B. Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med. 1991 Jun;84(6):371–371. doi: 10.1177/014107689108400622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grinspoon L., Bakalar J. B. Can drugs be used to enhance the psychotherapeutic process? Am J Psychother. 1986 Jul;40(3):393–404. doi: 10.1176/appi.psychotherapy.1986.40.3.393. [DOI] [PubMed] [Google Scholar]
  5. Gronert G. A. Malignant hyperthermia. Anesthesiology. 1980 Nov;53(5):395–423. doi: 10.1097/00000542-198011000-00007. [DOI] [PubMed] [Google Scholar]
  6. Hackl W., Mauritz W., Schemper M., Winkler M., Sporn P., Steinbereithner K. Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs. Br J Anaesth. 1990 Apr;64(4):425–429. doi: 10.1093/bja/64.4.425. [DOI] [PubMed] [Google Scholar]
  7. Halsall P. J., Cain P. A., Ellis F. R. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized. Br J Anaesth. 1979 Oct;51(10):949–954. doi: 10.1093/bja/51.10.949. [DOI] [PubMed] [Google Scholar]
  8. Henry J. A., Jeffreys K. J., Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") Lancet. 1992 Aug 15;340(8816):384–387. doi: 10.1016/0140-6736(92)91469-o. [DOI] [PubMed] [Google Scholar]
  9. Larner A. J. Complications of "ecstasy" misuse. Lancet. 1992 Sep 19;340(8821):726–726. [PubMed] [Google Scholar]
  10. Larner A. J. Dantrolene for exertional heatstroke. Lancet. 1992 Jan 18;339(8786):182–182. doi: 10.1016/0140-6736(92)90248-2. [DOI] [PubMed] [Google Scholar]
  11. McGuire N., Easy W. R. Malignant hyperthermia during isoflurane anaesthesia. Anaesthesia. 1990 Feb;45(2):124–127. doi: 10.1111/j.1365-2044.1990.tb14276.x. [DOI] [PubMed] [Google Scholar]
  12. McKenzie A. J., Couchman K. G., Pollock N. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. Anaesth Intensive Care. 1992 May;20(2):165–168. doi: 10.1177/0310057X9202000208. [DOI] [PubMed] [Google Scholar]
  13. Ording H. Incidence of malignant hyperthermia in Denmark. Anesth Analg. 1985 Jul;64(7):700–704. [PubMed] [Google Scholar]
  14. Parr M. J., Willatts S. M. Fatal theophylline poisoning with rhabdomyolysis. A potential role for dantrolene treatment. Anaesthesia. 1991 Jul;46(7):557–559. doi: 10.1111/j.1365-2044.1991.tb09655.x. [DOI] [PubMed] [Google Scholar]
  15. Peroutka S. J., Newman H., Harris H. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology. 1988 Dec;1(4):273–277. [PubMed] [Google Scholar]
  16. Prescott R. J., Roberts S. P., Williams G. Malignant hyperpyrexia: a rare cause of postoperative death. J Clin Pathol. 1992 Apr;45(4):361–363. doi: 10.1136/jcp.45.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ricaurte G., Bryan G., Strauss L., Seiden L., Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science. 1985 Sep 6;229(4717):986–988. doi: 10.1126/science.4023719. [DOI] [PubMed] [Google Scholar]
  18. Rittoo D. B., Rittoo D. Complications of "ecstasy" misuse. Lancet. 1992 Sep 19;340(8821):725–726. doi: 10.1016/0140-6736(92)92261-d. [DOI] [PubMed] [Google Scholar]
  19. Schmidt C. J., Black C. K., Abbate G. M., Taylor V. L. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors. Brain Res. 1990 Oct 8;529(1-2):85–90. doi: 10.1016/0006-8993(90)90813-q. [DOI] [PubMed] [Google Scholar]
  20. Screaton G. R., Singer M., Cairns H. S., Thrasher A., Sarner M., Cohen S. L. Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet. 1992 Mar 14;339(8794):677–678. doi: 10.1016/0140-6736(92)90834-p. [DOI] [PubMed] [Google Scholar]
  21. Singarajah C., Lavies N. G. An overdose of ecstasy. A role for dantrolene. Anaesthesia. 1992 Aug;47(8):686–687. doi: 10.1111/j.1365-2044.1992.tb02391.x. [DOI] [PubMed] [Google Scholar]
  22. Thomas D. W., Dev V. J., Whitehead M. J. Malignant hyperpyrexia and isoflurane. A case report. Br J Anaesth. 1987 Sep;59(9):1196–1198. doi: 10.1093/bja/59.9.1196. [DOI] [PubMed] [Google Scholar]
  23. Verebey K., Alrazi J., Jaffe J. H. The complications of 'ecstasy' (MDMA) JAMA. 1988 Mar 18;259(11):1649–1650. doi: 10.1001/jama.259.11.1649. [DOI] [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES